Literature DB >> 1700829

Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.

C Locardi1, C Petrini, G Boccoli, U Testa, C Dieffenbach, S Buttò, F Belardelli.   

Abstract

We have investigated the roles of cytokines in the modulation of human immunodeficiency virus (HIV) production in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3. HIV-infected U937 cells exhibited markedly lower levels of CD4 and HLA-DR antigens than uninfected cells did. Vitamin D3 induced a time-dependent macrophagelike differentiation, as determined by monitoring the expression of some surface antigens by means of the monoclonal antibodies OKM1, OKM5, OKM13, OKM14, OKT4, anti-HLA-DR, TecMG2, TecMG3, LeuM3, LeuM1, anti-HLA-DP, and anti-HLA-DQ. Treatment with hydroxyvitamin D3 resulted in a marked increase in HIV production compared with control cultures. Interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha) were detected in the culture media, whereas interferon (IFN) was not generally found. Using the polymerase chain reaction technique, we found HIV-infected U937 cells to express detectable levels of mRNAs for alpha interferon (IFN-alpha), IFN-beta, TNF-alpha, and IL-1 beta. The addition of TNF resulted in a marked increase of HIV production, whereas IL-1 beta was ineffective. In contrast, both IFN-alpha and IFN-beta exerted some inhibitory effect on HIV production, which was more marked in vitamin D3-treated cultures than in untreated cultures. HIV production was significantly increased by antibodies to IFN-alpha in both untreated and vitamin D3-treated cultures. Anti-IFN-beta antibody increased HIV production only in vitamin D3-treated cells. In contrast, anti-TNF-alpha antibodies markedly decreased HIV production in both control and differentiating U937 cells. Vitamin D3 treatment resulted in a higher expression of TNF receptors in differentiating cells than in control HIV-infected cells. These data demonstrate a strong correlation between HIV production and macrophagelike differentiation in chronically infected U937 cells and suggest that endogenous IFN and TNF exert opposite effects in the regulation of virus production in both undifferentiated and vitamin D3-treated cell cultures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700829      PMCID: PMC248750     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

2.  HIV replication can be blocked by recombinant human interferon beta.

Authors:  B Michaelis; J A Levy
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

3.  Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.

Authors:  G Poli; J M Orenstein; A Kinter; T M Folks; A S Fauci
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

4.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

5.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

7.  HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.

Authors:  D L Mann; E Read-Connole; L O Arthur; W G Robey; P Wernet; E M Schneider; W A Blattner; M Popovic
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Beta interferon subtype 1 induction by tumor necrosis factor.

Authors:  H Jacobsen; J Mestan; S Mittnacht; C W Dieffenbach
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

Review 9.  Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).

Authors:  S Roy; M A Wainberg
Journal:  J Leukoc Biol       Date:  1988-01       Impact factor: 4.962

10.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

View more
  18 in total

Review 1.  Nutrition and HIV infection in children.

Authors:  E E Mannick; J N Udall; M Kaiser; G Fuchs; R Suskind
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

2.  Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Authors:  Kristine M Erlandson; Ivy Gudza; Suzanne Fiorillo; Buxton Ndemera; Robert T Schooley; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2014-04-21       Impact factor: 3.623

3.  Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro.

Authors:  H Van Campen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.

Authors:  Allison Bearden; Cybele Abad; Ron Gangnon; James M Sosman; Neil Binkley; Nasia Safdar
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

5.  AIDS-related optic neuropathy: a histological, virological and ultrastructural study.

Authors:  A A Sadun; J S Pepose; M C Madigan; K A Laycock; W N Tenhula; W R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

6.  RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.

Authors:  C Martinand; C Montavon; T Salehzada; M Silhol; B Lebleu; C Bisbal
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.

Authors:  P Puddu; C Locardi; P Sestili; F Varano; C Petrini; A Modesti; L Masuelli; I Gresser; F Belardelli
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.

Authors:  A Roulston; P Beauparlant; N Rice; J Hiscott
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

Authors:  P R Skolnik; B Jahn; M Z Wang; T R Rota; M S Hirsch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Relationship between tumor necrosis factor alpha and feline immunodeficiency virus expressions.

Authors:  L A Kraus; W G Bradley; R W Engelman; K M Brown; R A Good; N K Day
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.